In breast cancer, high GLP1R expression was associated with better overall survival (HR = 0.76, logrank p = 0.0019), as was the case in esophageal adenocarcinoma (HR = 0.35, logrank p = 0.057), renal clear cell carcinoma (HR = 0.73, logrank p = 0.0086), kidney renal papillary cell carcinoma (HR = 0.62, logrank p = 0.099), and thyroid carcinoma (HR = 0.42, logrank p = 0.021). This evidence concerns the gene GLP1R and breast carcinoma.